SEVERITY SCORE FOR COVID-19 PNEUMONIA
Chỉ người dùng đã đăng ký mới có thể dịch các bài báo
Đăng nhập Đăng ký
Liên kết được lưu vào khay nhớ tạm
Trạng tháiTuyển dụng
Các nhà tài trợ
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
THỬ NGHIỆM LÂM SÀNG: NCT04372199
BioSeek: nct04372199
Từ khóa
trừu tượng
The outbreak of the coronavirus disease 2019 (COVID-19), first merged in China in December 2019, is now becoming a Public Health Emergency, recently confirmed as a pandemic disease by the World Health Organization.
In particular, since February 2020, a rapidly growing number of cases has been identified in Italy.
The clinical picture of ranges from asymptomatic cases, mild upper respiratory tract infections to severe pneumonia with respiratory failure and death. In most severe cases, COVID-19 disease may be complicated by acute respiratory distress syndrome (ARDS), septic shock and multiorgan failure.
It results fundamental to early identify those subjects who rapidly may worsen their clinical status, often requiring an intensive care unit (ICU) admission.
It has been showed that, mainly in more severe forms of SARS-Cov-2 disease, there is the development of an hyperinflammatory status resembling a cytokine storm syndrome, as already reported in SARS patients.
A recent study by Haung et al. reported that patients with COVID-19 infection showed high amounts of IL1B, IFN-gamma, IP10 and MCP1, probably linked to activated T-helper1 (Th1) cell responses. Those requiring ICU admission had higher levels of cytokines than those subjects not requiring ICU admission, thus suggesting that cytokine storm was associated with disease severity.
A similarity between cytokine profile of COVID-19 disease and secondary haemophagocytic syndrome (sHLH) has been reported. Therefore, it was suggested to screen all patients with severe COVID-19 infection both for hyperinflammatory markers (like ferritin), and the HScore commonly used to generate a probability for diagnosis of sHLH (8), which includes some laboratory parameters like triglycerides, fibrinogen, ferritin, serum aspartate aminostransferase.
Based on our experience on patients affected by pneumonia from Covid19, we have observed that those subjects with a more severe prognosis might have some predictive markers. We intend to verify if these markers can identify those subjects with Covid19 infection who need a more intensive therapy and to find a prognosis score.
ngày
Xác minh lần cuối: | 03/31/2020 |
Đệ trình đầu tiên: | 04/28/2020 |
Đăng ký ước tính đã được gửi: | 04/28/2020 |
Đăng lần đầu: | 04/30/2020 |
Cập nhật lần cuối được gửi: | 04/28/2020 |
Cập nhật lần cuối đã đăng: | 04/30/2020 |
Ngày bắt đầu nghiên cứu thực tế: | 04/28/2020 |
Ngày hoàn thành chính ước tính: | 05/26/2020 |
Ngày hoàn thành nghiên cứu ước tính: | 05/26/2020 |
Tình trạng hoặc bệnh tật
COVID
Pneumonia
Giai đoạn
-
Đủ tiêu chuẩn
Tuổi đủ điều kiện để học | 18 Years Đến 18 Years |
Giới tính đủ điều kiện để nghiên cứu | All |
Phương pháp lấy mẫu | Probability Sample |
Chấp nhận tình nguyện viên lành mạnh | Đúng |
Tiêu chí | Inclusion Criteria: Patients with diagnosis of pneumonia, confirmed by chest imaging, Covid-19 test positive Exclusion Criteria: Age lower than 18 years, pregnancy or breast-feeding |
Kết quả
Các biện pháp kết quả chính
1. To identify the best predictors of critical coronavirus pneumonia and to realize a simple severity score able to early classify high-risk individuals admitted to Internal Medicine Department for COVID-19 disease, needing an intensive approach [1 month]